Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Drotaverine Hydrochloride Tablets

Approval Number

国药准字H20020296

Company赛诺菲（杭州）制药有限公司

Registration Date

December 10, 2019

Drug Information

Generic Name

盐酸屈他维林片

Trade Name

诺仕帕

Brand Name

诺仕帕

Dosage Form

片剂

Strength

40mg(以C24H31NO4·HCl计)

Drug Type

化学药品

Registration Date

December 10, 2019

Company Information

Applicant Company

Company Name赛诺菲（杭州）制药有限公司

Manufacturing Company

Company Name赛诺菲（杭州）制药有限公司

Company Address

杭州市滨江区江陵路325号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy